The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism
- PMID: 8293350
The relationship between serum intact parathyroid hormone and calcium in idiopathic hypoparathyroidism
Abstract
We studied the relationship between serum calcium (Ca) and parathyroid hormone (PTH) in patients with idiopathic hypoparathyroidism (IHP) to investigate the diversity of the degree of parathyroid insufficiency and a regulation of PTH secretion by Ca in IHP. Serum intact PTH concentrations ranged from < 1.0 to 10.3 pg/ml in 20 patients with IHP and were above the detection limit in 18 (90%) patients. Serum total Ca levels in IHP were positively correlated with serum intact PTH (r = 0.824, P < 0.001), in contrast with a negative correlation between serum intact PTH and Ca in 91 normal subjects (r = -0.378, P < 0.001) and abnormally high serum intact PTH values against hypocalcemia in five patients with pseudohypoparathyroidism. In three patients with IHP, serum intact PTH decreased in response to treatment with active vitamin D3 which increased serum Ca and 1,25(OH)2D. An inverse sigmoidal relationship between serum ionized Ca and intact PTH was demonstrated in a patient with IHP before treatment [IHP(-)] and three patients with IHP treated with active vitamin D3[IHP(+)]. Peak serum intact PTH values were reduced in IHP(-) and IHP(+). Baseline serum intact PTH was 77.0% of the maximal level in IHP(-), 51.7-72.1% in IHP(+), and 31.1-42.3% in five normal subjects. The degree of parathyroid dysfunction in IHP differs from one patient to another and serum Ca levels are thought to be determined by circulating PTH levels. Although PTH secretory reserve is diminished, PTH secretion is negatively regulated by Ca and is stimulated at baseline in patients with IHP before and during the treatment with active vitamin D3.
Similar articles
-
Response of plasma 1,25-dihydroxyvitamin D in the human PTH(1-34) infusion test: an improved index for the diagnosis of idiopathic hypoparathyroidism and pseudohypoparathyroidism.Calcif Tissue Int. 1990 May;46(5):309-13. doi: 10.1007/BF02563821. Calcif Tissue Int. 1990. PMID: 2159833
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Sigmoidal curve shift in idiopathic hypoparathyroidism and pseudohypoparathyroidism.Calcif Tissue Int. 1998 Apr;62(4):290-4. doi: 10.1007/s002239900433. Calcif Tissue Int. 1998. PMID: 9504951
-
Effects of active vitamin D3 and parathyroid hormone on the serum osteocalcin in idiopathic hypoparathyroidism and pseudohypoparathyroidism.J Clin Invest. 1988 Sep;82(3):861-5. doi: 10.1172/JCI113690. J Clin Invest. 1988. PMID: 2843573 Free PMC article.
-
[Pseudohypoparathyroidism: investigations of the serum parathyroid hormone level, pte resistance and urinary camp excretion before and during vitamin d treatment (author's transl)].Wien Klin Wochenschr Suppl. 1975;33:1-15. Wien Klin Wochenschr Suppl. 1975. PMID: 176830 Review. German.
Cited by
-
Resetting of parathyroid hormone secretion after vitamin D3 treatment in hypoparathyroidism and after parathyroid adenectomy in primary hyperparathyroidism.Calcif Tissue Int. 1995 Jul;57(1):30-4. doi: 10.1007/BF00298993. Calcif Tissue Int. 1995. PMID: 7671162